Bae S, Shahbazian A, Wang J, Markovic D, De Leon T, Lee Y
Arthritis Res Ther. 2025; 27(1):53.
PMID: 40055821
PMC: 11889823.
DOI: 10.1186/s13075-025-03520-z.
Vernerova L, Vokurkova M, Laiferova N, Nemec M, Spiritovic M, Mytiai O
Arthritis Res Ther. 2025; 27(1):48.
PMID: 40038731
PMC: 11877867.
DOI: 10.1186/s13075-025-03516-9.
Seese F, Roscher P, Coppers B, Greenfield J, Grahammer M, Kuhn S
Arthritis Res Ther. 2025; 27(1):38.
PMID: 39987452
PMC: 11846393.
DOI: 10.1186/s13075-025-03504-z.
Ardalan K, Marques M, Cella D, Curran M, Gray E, Lee J
Semin Arthritis Rheum. 2025; 71:152649.
PMID: 39933204
PMC: 11890175.
DOI: 10.1016/j.semarthrit.2025.152649.
Pandya R, Dan J, Kleitsch J, Lim D, White B, Werth V
JID Innov. 2025; 5(2):100337.
PMID: 39877684
PMC: 11773231.
DOI: 10.1016/j.xjidi.2024.100337.
Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry.
Cobo-Ibanez T, Castellvi I, Pros A, Dominguez-Alvaro M, Nuno-Nuno L, Martinez-Barrio J
Arthritis Res Ther. 2025; 27(1):5.
PMID: 39780297
PMC: 11707992.
DOI: 10.1186/s13075-024-03471-x.
The value of quantitative muscle ultrasound in monitoring muscle and fascia inflammatory activity in juvenile dermatomyositis patients.
Liu L, Wang X, Wang Y, Wang M, Ma Y, Li J
Quant Imaging Med Surg. 2024; 14(12):8601-8613.
PMID: 39698728
PMC: 11651955.
DOI: 10.21037/qims-24-1035.
Development of a machine learning model in prediction of the rapid progression of interstitial lung disease in patients with idiopathic inflammatory myopathy.
Qiang Y, Wang H, Ni Y, Wang J, Liu A, Yang H
Quant Imaging Med Surg. 2024; 14(12):9258-9275.
PMID: 39698644
PMC: 11652001.
DOI: 10.21037/qims-24-595.
Relationship between high-resolution computed tomography quantitative imaging analysis and physiological and clinical features in antisynthetase syndrome-related interstitial lung disease.
Bae S, Abtin F, Kim G, Markovic D, Chan C, Moghadam-Kia S
RMD Open. 2024; 10(4).
PMID: 39608864
PMC: 11603737.
DOI: 10.1136/rmdopen-2024-004592.
Neutrophil and mononuclear leukocyte pathways and upstream regulators revealed by serum proteomics of adult and juvenile dermatomyositis.
Sparling A, Ward J, Sarkar K, Schiffenbauer A, Noroozi Farhadi P, Smith M
Arthritis Res Ther. 2024; 26(1):196.
PMID: 39529136
PMC: 11552237.
DOI: 10.1186/s13075-024-03421-7.
Quantification of autoantibodies using a luminescent profiling method in autoimmune interstitial lung disease.
Burbelo P, Huapaya J, Khavandgar Z, Beach M, Pinal-Fernandez I, Mammen A
Front Immunol. 2024; 15:1462242.
PMID: 39524452
PMC: 11543486.
DOI: 10.3389/fimmu.2024.1462242.
Ringing in the Patient Voice: Measuring Patients' Lived Experience of Dermatomyositis Symptoms.
Ardalan K, Rider L
J Rheumatol. 2024; 51(12):1156-1159.
PMID: 39486855
PMC: 11611614.
DOI: 10.3899/jrheum.2024-0951.
Increased Cytokine Levels in Seronegative Myositis: Potential Th17 Immune Response Implications.
Aguilar-Vazquez A, Chavarria-Avila E, Gutierrez-Hernandez J, Toriz-Gonzalez G, Salazar-Paramo M, Medrano-Ramirez G
Int J Mol Sci. 2024; 25(20).
PMID: 39456842
PMC: 11508411.
DOI: 10.3390/ijms252011061.
Updates in Dermatomyositis: Newer Treatment Options and Outcome Measures From Dermatologic Perspectives.
Kim H, Werth V
Ann Dermatol. 2024; 36(5):257-265.
PMID: 39343752
PMC: 11439981.
DOI: 10.5021/ad.24.022.
Association of anti-HMGCR antibodies of the IgM isotype with refractory immune-mediated necrotizing myopathy.
Yang H, Sun C, Ye L, Xu Y, Lin S, Peng Q
Arthritis Res Ther. 2024; 26(1):158.
PMID: 39261921
PMC: 11389351.
DOI: 10.1186/s13075-024-03387-6.
High-intensity resistance training improves quality of life, muscle endurance and strength in patients with myositis: a randomised controlled trial.
Jensen K, Aagaard P, Suetta C, Nielsen J, Bech R, Schroder H
Rheumatol Int. 2024; 44(10):1909-1921.
PMID: 39192022
PMC: 11392978.
DOI: 10.1007/s00296-024-05698-y.
Clinico-sero-pathological profiles and risk prediction model of idiopathic inflammatory myopathy (IIM) patients with different perifascicular changes.
Zhang L, Fu L, Zhang G, Hou Y, Ma X, Zhao D
CNS Neurosci Ther. 2024; 30(8):e14882.
PMID: 39097917
PMC: 11298199.
DOI: 10.1111/cns.14882.
Familial clustering of dysbiotic oral and fecal microbiomes in juvenile dermatomyositis.
Koester S, Chow A, Pepper-Tunick E, Lee P, Eckert M, Brenchley L
Sci Rep. 2024; 14(1):16158.
PMID: 38997299
PMC: 11245510.
DOI: 10.1038/s41598-024-60225-0.
Development of the Cutaneous Dermatomyositis Investigator Global Assessment (CDM-IGA): A De Novo IGA of Cutaneous Manifestations of Dermatomyositis.
McKee S, Xenakis J, Makin H, Marshall C, Winnette R, Aggarwal R
Dermatol Ther (Heidelb). 2024; 14(8):2127-2138.
PMID: 38976170
PMC: 11333384.
DOI: 10.1007/s13555-024-01220-1.
Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis.
Galindo-Feria A, Lodin K, Horuluoglu B, Sarrafzadeh-Zargar S, Wigren E, Graslund S
Rheumatology (Oxford). 2024; 64(3):1482-1492.
PMID: 38833674
PMC: 11879316.
DOI: 10.1093/rheumatology/keae317.